<code id='6D5287AF7D'></code><style id='6D5287AF7D'></style>
    • <acronym id='6D5287AF7D'></acronym>
      <center id='6D5287AF7D'><center id='6D5287AF7D'><tfoot id='6D5287AF7D'></tfoot></center><abbr id='6D5287AF7D'><dir id='6D5287AF7D'><tfoot id='6D5287AF7D'></tfoot><noframes id='6D5287AF7D'>

    • <optgroup id='6D5287AF7D'><strike id='6D5287AF7D'><sup id='6D5287AF7D'></sup></strike><code id='6D5287AF7D'></code></optgroup>
        1. <b id='6D5287AF7D'><label id='6D5287AF7D'><select id='6D5287AF7D'><dt id='6D5287AF7D'><span id='6D5287AF7D'></span></dt></select></label></b><u id='6D5287AF7D'></u>
          <i id='6D5287AF7D'><strike id='6D5287AF7D'><tt id='6D5287AF7D'><pre id='6D5287AF7D'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:6812
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Elisabeth Bik tackles the widespread issue of research misconduct
          Elisabeth Bik tackles the widespread issue of research misconduct

          AlexHogan/STATElisabethBik,amicrobiologistbytraining,hasbecomeoneoftheworld’smostinfluentialscienced

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Bispecific antibodies are next new thing in cancer immunotherapy

          IllustrationofaBiTE,Amgen'sbispecificantibodiesAmgenIncancerimmunotherapythesedays,technologyisadvan